Philadelphia Medical Technology Company, Proscia, Raises $37M Series C Round
Philadelphia medical technology company Proscia raised a $37 million Series C funding round, doubling what it has taken in from investors since its inception eight years ago.
Founded in 2014 by a team of biomedical engineers from Johns Hopkins University and the University of Pittsburgh, the company uses artificial intelligence to improve how pathologists diagnose cancer.
Read the full article at: www.bizjournals.com
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.